{
  "id": 9819754,
  "title": "FDA approves Mirum’s drug for ultra-rare soft tissue disease",
  "url": "https://urgent.news/2026/09/25/fda-approves-mirums-drug-for-ultra-rare-soft-tissue-disease",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-25T19:46:36.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/fda-approves-mirums-drug-for-ultra-rare-soft-tissue-disease/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The FDA has approved the third treatment for a debilitating genetic disease that turns muscle and connective tissue to bone. Mirum Pharmaceuticals’ zilurgisertib, which blocks the ALK2 receptor, will be marketed as Atebrioz for patients ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}